Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00201214 · ClinicalTrials.gov registry record · Phase 1
Citrulline for Children Undergoing Cardiopulmonary Bypass Surgery
A Phase 1 study, sponsored by Vanderbilt University.
- Completed
- Registry status
- Phase 1
- Development phase
- 26
- Enrollment target
NCT00201214 is a Phase 1 study that has completed, run by Vanderbilt University. The registered enrollment target is 26 participants.
The verdict
NCT00201214, a Phase 1 study, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 26 participants
- Enrollment target
Study Summary
This study will determine the pharmacokinetics and safety of intravenous citrulline given to children undergoing cardiopulmonary bypass for the correction of congenital heart defects.
Interventions
- DRUG Citrulline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2003-12 |
| Est. Completion | 2009-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00201214
The ClinicalTrials.gov registry entry for NCT00201214 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Citrulline is the first listed.
NCT00201214 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00201214 about?
NCT00201214 is a clinical study titled "Citrulline for Children Undergoing Cardiopulmonary Bypass Surgery". This study will determine the pharmacokinetics and safety of intravenous citrulline given to children undergoing cardiopulmonary bypass for the correction of congenital heart defects.
What is the current status of trial NCT00201214?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 26 participants. The study started on 2003-12. Estimated completion is 2009-12.
What interventions are being tested in trial NCT00201214?
The interventions under investigation include: Citrulline (DRUG).
Who is sponsoring clinical trial NCT00201214?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.